Cole Maguire retweeted
A new @Nature study led by Dell Med researchers found COVID-19 can awaken dormant viruses many people carry. In 1,100+ hospitalized patients, viral reactivation was linked to worse outcomes and may help explain some long COVID symptoms. bit.ly/3UdvYgU
Cole Maguire retweeted
Out Now in @Nature Led by @DellMedSchool along with @PrecVaccines and 13 biomedical research institutions across the United States, the #IMPACC group have discovered that #COVID19 reactivates multiple dormant viruses in hospitalized patients correlating with development of acute and #longCOVID. These findings expand understanding of chronically infecting viruses and could inform development of strategies to combat their reactivation. @MelamedEsther @colemag9, Jing Chen, Annmarie Hoch, Al Ozonoff, @KingaSmolen, @levy_o, Hanno Steen, @JoannDArce #Coronavirus
Read full article here: nature.com/articles/s41586-0…
Cole Maguire retweeted
Honored to share our Nature paper. In >1,000 hospitalized COVID-19 patients, ~50% had reactivation of dormant viruses creating a "dysvirosis" linked to worse acute COVID-19 and Long COVID outcomes. nature.com/articles/s41586-0… #LongCOVID #DellMed
I'm excited to announce our work on viral reactivation and dysvirosis in COVID-19 is now out in Nature! This paper explores the dynamic endogenous viral landscape in COVID-19, and shows correlation with clinical outcomes for patients.
nature.com/articles/s41586-0…
This work was truly a team effort, and I am incredibly grateful to all our co-authors and collaborators across the #IMPACC Consortium! Most importantly, we're especially grateful to the patients whose participation made this research possible!
1
16
Cole Maguire retweeted
Excited to share our study in 977 #LongCOVID patients, identifying persistent anti-ganglioside antibodies as key in LC neuropathy, providing evidence for autoimmune etiology and IVIG benefits in reversing symptoms. #Neuropathy #AutoimmuneDisease @colemag9 medrxiv.org/content/10.1101/…
Super excited to announce our pre-print evaluating Long COVID neuropathy is out! Importantly, we found anti-ganglioside antibodies (often seen in autoimmune neuropathies) in 25% of Long COVID neuropathy patients. medrxiv.org/content/10.1101/…
Cole Maguire retweeted
Excited to share our latest #IMPACC study on patient subtype discovery using longitudinal multi-omics! We identified 5 subtypes among 1,000+ hospitalized #COVID19 patients, highlighting the link between distinct immune responses in those with similar respiratory status to various acute complications and #LongCOVID risk. biorxiv.org/content/10.1101/…
This work is co-led by wonderful students Kexin, Yutong, @colemag9, collaborators @VirusesImmunity, @JoannDArce, Lauren, and the #IMPACC consortium team.
I’m excited to announce that our paper on viral molecular mimicry just came out! Molecular mimicry occurs when pathogens “mimic” host protein structure. Here, we explore mimicry across the human virome and its connection to autoimmunity. @MelamedEsther
nature.com/articles/s41467-0…
Cole Maguire retweeted
Our recent #IMPACC #COVID19 #multiomics study published in @jclinicalinvest is featured in @yalemed! Read about it:
"COVID-19: New ‘Omics’ Models Show Why Some People Are at Greater Risk of Severe Disease, Death"
m.yale.edu/ckst
@LeyingGuan @colemag9 @sciRPatel
Cole Maguire retweeted
I am excited to share that our #IMPACC paper - Integrated longitudinal multi-omics study identifies immune programs associated with acute COVID-19 severity and mortality - was recently published in @jclinicalinvest. jci.org/articles/view/176640 #SystemsBiology #Bioinformatics [1/5]
Cole Maguire retweeted
Our #IMPACC aging manuscript is published. Kudos to lead authors @HoangVanPhan2 @ATsitsiklis @colemag9 and Chaz Langelier.
Why are older adults much more susceptible to severe Covid? Multiple liabilities: reduced ability to clear the virus, immune signaling dysregulation, and an untoward pro-inflammatory response of genes and proteins
science.org/doi/10.1126/scit… @ScienceTM
Cole Maguire retweeted
Excited to share my latest research on #COVID19 and #aging, together with @ATsitsiklis and @colemag9, that just came out on @ScienceTM!
teapaw.org/czbiohub/status/178099…
A new study led by #CZBiohubSF & @UCSF researchers provides fresh insights into why age is a major risk factor for severe #COVID. It is the most comprehensive analysis to date of how age affects the immune response to #SARSCoV2. 1/7
Read in @ScienceTM ⤵️
bit.ly/4aUR2Mc













